Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bolt Biotherapeutics Q2 EPS $(0.48) Up From $(0.61) YoY, Sales $1.43M Up From $1.39M YoY

Author: Benzinga Newsdesk | August 07, 2023 04:55pm
Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(0.48) per share. This is a 21.31 percent increase over losses of $(0.61) per share from the same period last year. The company reported $1.43 million in sales this quarter. This is a 2.87 percent increase over sales of $1.39 million the same period last year.

Posted In: BOLT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist